logo

Last Update

This profile was last updated on 8/11/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Kelly Oliner?

Kelly S. Oliner

Research Scientist

Amgen Inc.

HQ Phone:  (805) 447-1000

Direct Phone: (805) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Amgen Inc.

One Amgen Center Dr.

Thousand Oaks, California,91320

United States

Company Description

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to u...more

Background Information

Employment History

Research Scientist

Chiron Corp.


Research Scientist

Protein Pathways , Inc.


Affiliations

Clinical and Laboratory Standards Institute

Board Member


Education

Ph.D.


PhD

Molecular Genetics

Johns Hopkins University School of Medicine


Web References(14 Total References)


CLSI Board of Directors: Active Advocates for Our Vision

clsi.org [cached]

Kelly S. Oliner, PhD
US Food and Drug Administration Kelly S. Oliner, PhD, is the Deputy Director, Division of Immunology and Hematology Devices in FDA's Office of In Vitro Diagnostic Devices and Radiological Safety. She earned her PhD in Molecular Genetics from the Johns Hopkins University School of Medicine and subsequently held two post-doctoral fellowships at Somatix Gene Therapy Corporation and Chiron Corporation. Following these fellowships, she was a research scientist at Chiron Corporation, Protein Pathways, and Amgen. While at Amgen (2003-2015), Dr. Oliner held successive positions from Staff Scientist to Scientific Director. Initially, she managed a laboratory group that developed and validated therapeutic drug potency assays in a GLP testing environment. In 2006, Dr. Oliner transferred to the clinical biomarker group where she was responsible for leading biomarker development efforts for clinical programs from early preclinical stage to marketed products. In this position, she had a small laboratory group that developed and validated biomarker assays (ELISA, RT-PCR, NGS) for use in Amgen clinical trials. Dr. Oliner also lead extensive outsourcing efforts (ELISA, IHC, FISH, PCR, and NGS) to small and large clinical testing laboratories in the US, Europe, and China to support global clinical trials. Several clinical biomarker efforts were successful. In 2012, Amgen formed a small, specialized in vitro diagnostic group to specifically support companion diagnostic programs at Amgen. Through collaborative partnerships with diagnostic companies, clinically validated biomarker assays were developed. Dr. Oliner led long-term efforts to develop, validate, and obtain global regulatory approval for KRAS and RAS biomarkers for the use of panitumumab, and EGFR antibody for colorectal carcinoma.


CLSI Board of Directors: Board Member Profiles

clsi.org [cached]

Kelly S. Oliner, PhD
US Food and Drug Administration Kelly S. Oliner, PhD is the Deputy Director, Division of Immunology and Hematology Devices in FDA's Office of In Vitro Diagnostic Devices and Radiological Safety. She earned her PhD in Molecular Genetics from the Johns Hopkins University School of Medicine and subsequently held two post-doctoral fellowships at Somatix Gene Therapy Corporation and Chiron Corporation. Following these fellowships, she was a research scientist at Chiron Corporation, Protein Pathways, and Amgen. While at Amgen (2003-2015), Dr. Oliner held successive positions from Staff Scientist to Scientific Director. Initially, she managed a laboratory group that developed and validated therapeutic drug potency assays in a GLP testing environment. In 2006, Dr. Oliner transferred to the clinical biomarker group where she was responsible for leading biomarker development efforts for clinical programs from early preclinical stage to marketed products. In this position, she had a small laboratory group that developed and validated biomarker assays (ELISA, RT-PCR, NGS) for use in Amgen clinical trials. Dr. Oliner also lead extensive outsourcing efforts (ELISA, IHC, FISH, PCR, and NGS) to small and large clinical testing laboratories in the US, Europe, and China to support global clinical trials. Several clinical biomarker efforts were successful. In 2012, Amgen formed a small, specialized in vitro diagnostic group to specifically support companion diagnostic programs at Amgen. Through collaborative partnerships with diagnostic companies, clinically validated biomarker assays were developed. Dr. Oliner led long-term efforts to develop, validate, and obtain global regulatory approval for KRAS and RAS biomarkers for the use of panitumumab, and EGFR antibody for colorectal carcinoma.


Farrar Clenches First Win & First U.S. Rider Victory of 2013 AMGEN Tour of California

www.uscyclingreport.com [cached]

Rantanen was joined by approximately 150 community members - cancer survivors, patients, caregivers, and advocates - and Kelly Oliner, scientific director of Medical Sciences at Amgen, who plays a crucial role in developing innovative medicines to treat cancer and other serious illnesses.


world-cdx.com

Kelly Oliner Scientific Director, Medical Sciences, Amgen


world-cdx.com

Kelly Oliner, Scientific Director, Amgen
Download the program for full details on the streams


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory